Want to see FR:ALAFY full AI Analyst Report?
Top Page
AFYREN
(ALAFY)
Select Model
Select Model
Rating:49Neutral
Price Target:
€3.00
▲(9.49% Upside)
Action:Reiterated
Date:06/17/26
The score is held down primarily by weak financial performance (shrinking revenue, deepening losses, and persistent negative free cash flow), partly cushioned by a relatively low-debt balance sheet. Technicals are only mildly supportive with mixed momentum, and valuation is challenged by ongoing losses and no dividend information.
Positive Factors
Proprietary fermentation technology
AFYREN's proprietary fermentation process is a durable competitive asset: it enables production of renewable organic acids from biomass residues, creates technical barriers to entry, and aligns the company with long-term secular demand for sustainable chemical substitutes across industries, supporting lasting product differentiation and customer lock-in.
Negative Factors
Sustained revenue decline
Two consecutive years of double-digit revenue declines signal weak commercial traction or demand shifts. Loss of scale erodes unit economics and makes fixed-cost absorption harder, lengthening the timeline to profitable operations and complicating contract offtake scaling critical for durable revenue recovery.
Read all positive and negative factors
Positive Factors
Negative Factors
Proprietary fermentation technology
AFYREN's proprietary fermentation process is a durable competitive asset: it enables production of renewable organic acids from biomass residues, creates technical barriers to entry, and aligns the company with long-term secular demand for sustainable chemical substitutes across industries, supporting lasting product differentiation and customer lock-in.
Read all positive factors
AFYREN (ALAFY) vs. iShares MSCI France ETF (EWQ)
Market Cap
€105.10M
Dividend YieldN/A
Average Volume (3M)11.73K
Price to Earnings (P/E)―
Beta (1Y)-0.11
Revenue Growth-20.58%
EPS Growth-41.43%
CountryFR
Employees121
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)-0.53
Shares Outstanding38,852,520
10 Day Avg. Volume14,319
30 Day Avg. Volume11,733
Financial Highlights & Ratios
PEG Ratio-0.12
Price to Book (P/B)1.22
Price to Sales (P/S)33.31
P/FCF Ratio-14.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.6
Revenue Forecast (FY)€4.10M
AFYREN Business Overview & Revenue Model
Company Description
AFYREN SAS provides biobased products to replace petroleum-based molecules in France. The company offers acetic, propionic, butyric and isobutyric, valeric and isovaleric, and caproic acids. Its products are used in the flavors and fragrances, lub...
How the Company Makes Money
AFYREN makes money primarily by selling bio-based organic acids and derived products produced through its proprietary fermentation process. Its core revenue stream is product sales (B2B), where customers purchase specific acids (and potentially bl...
AFYREN Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
62
Positive
Cash Flow
24
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.27M | 2.86M | 3.38M | 3.46M | 3.04M |
| Gross Profit | -5.49M | -174.00K | 645.00K | 1.06M | 1.47M |
| EBITDA | -6.81M | -8.81M | -8.59M | -4.71M | -2.78M |
| Net Income | -14.37M | -9.75M | -9.59M | -9.20M | -3.61M |
Balance Sheet | |||||
| Total Assets | 67.14M | 58.56M | 70.43M | 84.82M | 93.15M |
| Cash, Cash Equivalents and Short-Term Investments | 35.16M | 33.65M | 49.66M | 62.40M | 67.36M |
| Total Debt | 2.42M | 3.31M | 4.79M | 8.54M | 8.95M |
| Total Liabilities | 4.19M | 5.86M | 8.63M | 13.84M | 15.29M |
| Stockholders Equity | 62.10M | 52.70M | 61.80M | 70.98M | 77.86M |
Cash Flow | |||||
| Free Cash Flow | -5.29M | -5.84M | -5.60M | -3.83M | -3.06M |
| Operating Cash Flow | -5.09M | -5.62M | -5.04M | -3.30M | -2.71M |
| Investing Cash Flow | -15.25M | -9.11M | -3.08M | -362.00K | -436.00K |
| Financing Cash Flow | 21.96M | -1.28M | -4.66M | -1.14M | 60.77M |
AFYREN Technical Analysis
Negative
2.74
Price Trends
2.79
Negative
2.69
Positive
2.75
Negative
Market Momentum
-0.02
Positive
44.60
Neutral
43.54
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:ALAFY, the sentiment is Negative. The current price of 2.74 is below the 20-day moving average (MA) of 2.76, below the 50-day MA of 2.79, and below the 200-day MA of 2.75, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 44.60 is Neutral, neither overbought nor oversold. The STOCH value of 43.54 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:ALAFY.
AFYREN Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | €106.06B | 28.51 | 13.42% | 1.84% | -1.30% | 3.05% | |
68 Neutral | €1.52B | 15.39 | ― | 1.79% | 4.50% | 16.15% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | €85.50M | 22.84 | 7.97% | 1.29% | 6.27% | -0.96% | |
60 Neutral | €4.32B | 100.00 | 0.92% | 6.32% | -5.73% | -73.67% | |
49 Neutral | €105.10M | -5.10 | -26.54% | ― | -20.58% | -41.43% | |
44 Neutral | €96.17M | -2.80 | -18.56% | ― | ― | ― |
* Basic Materials Sector Average
FR:ALAFY
AFYREN
2.71
0.18
6.92%
FR:AI
Air Liquide
166.52
8.85
5.61%
FR:AKE
Arkema
57.00
1.27
2.29%
FR:ALCRB
Carbios SA
5.69
-3.99
-41.19%
FR:ALBKK
Baikowski SA
23.30
4.23
22.19%
FR:CBE
Robertet SA Cert.d'Invest. Em.87
669.00
-37.60
-5.32%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.